Feifei Mao, Yuqiang Cheng, Kang Wang, Zongtao Chai, Lei Guo, Yanyan Xu, . . . Shuqun Cheng. (2024). The KIT ligand KITLG promotes portal vein tumor thrombosis by up-regulating COL4A1 through STAT3-SMAD2 signaling in hepatocellular carcinoma. Compuscript Ltd.
Chicago Style (17th ed.) CitationFeifei Mao, et al. The KIT Ligand KITLG Promotes Portal Vein Tumor Thrombosis by Up-regulating COL4A1 Through STAT3-SMAD2 Signaling in Hepatocellular Carcinoma. Compuscript Ltd, 2024.
MLA (9th ed.) CitationFeifei Mao, et al. The KIT Ligand KITLG Promotes Portal Vein Tumor Thrombosis by Up-regulating COL4A1 Through STAT3-SMAD2 Signaling in Hepatocellular Carcinoma. Compuscript Ltd, 2024.
Warning: These citations may not always be 100% accurate.